AAAAAA
Results:
1-18
|
Results: 18
Authors:
WEISS R
HUHN D
MITROU P
NERL C
SCHURMANN D
SCHEIDEGGER C
KNAUF W
TRENN G
KRONAWITTER U
VANLUNZEN J
ARASTEH K
HERBST H
Citation: R. Weiss et al., HIV-RELATED NON-HODGKINS-LYMPHOMA - CHOP INDUCTION THERAPY AND INTERFERON-ALPHA-2B ZIDOVUDINE MAINTENANCE THERAPY/, Leukemia & lymphoma, 29(1-2), 1998, pp. 103-118
Authors:
STEWART S
JABLONOWSKI H
GOEBEL FD
ARASTEH K
SPITTLE M
RIOS A
ABOULAFIA D
GALLESHAW J
DEZUBE BJ
Citation: S. Stewart et al., RANDOMIZED COMPARATIVE TRIAL OF PEGYLATED LIPOSOMAL DOXORUBICIN VERSUS BLEOMYCIN AND VINCRISTINE IN THE TREATMENT OF AIDS-RELATED KAPOSIS-SARCOMA, Journal of clinical oncology, 16(2), 1998, pp. 683-691
Authors:
ARASTEH K
CORDES C
FUTH U
GROSSE G
DIETZ E
STAIB F
Citation: K. Arasteh et al., COINFECTION BY CRYPTOCOCCUS-NEOFORMANS AND MYCOBACTERIUM-AVIUM-INTRACELLULARE IN AIDS - CLINICAL AND EPIDEMIOLOGIC ASPECTS, Mycopathologia, 140(3), 1998, pp. 115-120
Authors:
KUROWSKI M
SCHMIDT A
ARASTEH K
MOCKLINGHOFF C
Citation: M. Kurowski et al., SIMULTANEOUS DETERMINATION OF PROTEASE INHIBITORS USING LC-TANDEM MASS-SPECTROMETRY IN HIV-INFECTED PATIENTS, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 4941-4941
Authors:
WEISS R
HUHN D
MITROU P
NERL C
SHURMANN D
SCHEIDEGGER C
KNAUF W
TRENN G
KRONAWITTER U
VANLUNZEN J
ARASTEH K
HERBST H
Citation: R. Weiss et al., HIV-RELATED NON-HODGKINS-LYMPHOMA - CHOP INDUCTION THERAPY AND INTERFERON-A-2B ZIDOVUDINE MAINTENANCE THERAPY/, Journal of acquired immune deficiency syndromes and human retrovirology, 14(4), 1997, pp. 91-91
Authors:
ARASTEH K
HEIL HD
REUPKE H
KUHNLPETZOLDT C
GROSSE G
FUTH U
STAIB F
Citation: K. Arasteh et al., DISSEMINATED CRYPTOCOCCOSIS WITH EXTENSIV E SKIN INVOLVEMENT IN AIDS, Medizinische Klinik, 92(6), 1997, pp. 354-357
Authors:
HEISHMAN SJ
ARASTEH K
STITZER ML
Citation: Sj. Heishman et al., COMPARATIVE EFFECTS OF ALCOHOL AND MARIJUANA ON MOOD, MEMORY, AND PERFORMANCE, Pharmacology, biochemistry and behavior, 58(1), 1997, pp. 93-101
Authors:
HEISE W
ARASTEH K
MOSTERTZ P
SKORDE J
SCHMIDT W
OBST C
KOEPPEN M
WEISS R
GROSSE G
NIEDOBITEK F
LAGE M
Citation: W. Heise et al., MALIGNANT GASTROINTESTINAL LYMPHOMAS IN PATIENTS WITH AIDS, Digestion, 58(3), 1997, pp. 218-224
Authors:
ARASTEH K
STAIB F
GROSSE G
FUTH U
LAGE M
Citation: K. Arasteh et al., CRYPTOCOCCOSIS IN HIV-INFECTION OF MAN - AN EPIDEMIOLOGIC AND IMMUNOLOGICAL INDICATOR, Zentralblatt fur Bakteriologie, 284(2-3), 1996, pp. 153-163
Authors:
BEK B
BOECKH M
LEPENIES J
BIENIEK B
ARASTEH K
HEISE W
DEPPERMANN KM
BORNHOFT G
STOFFLERMEILICKE M
SCHULLER I
HOFFKEN G
Citation: B. Bek et al., HIGH-LEVEL SENSITIVITY OF QUANTITATIVE PP65 CYTOMEGALOVIRUS (CMV) ANTIGENEMIA ASSAY FOR DIAGNOSIS OF CMV DISEASE IN AIDS PATIENTS AND FOLLOW-UP (VOL 34, PG 458, 1996), Journal of clinical microbiology, 34(5), 1996, pp. 1350-1350
Authors:
BEK B
BOECKH M
LEPENIES J
BIENIEK B
ARASTEH K
HEISE W
DEPPERMANN KM
BORNHOFT G
STOFFLERMEILICKE M
SCHULLER I
HOFFKEN G
Citation: B. Bek et al., HIGH-LEVEL SENSITIVITY OF QUANTITATIVE PP65 CYTOMEGALOVIRUS (CMV) ANTIGENEMIA ASSAY FOR DIAGNOSIS OF CMV DISEASE IN AIDS PATIENTS AND FOLLOW-UP, Journal of clinical microbiology, 34(2), 1996, pp. 457-459
Authors:
ARASTEH K
LAGE M
FUTH U
GROSSE G
STAIB F
Citation: K. Arasteh et al., CD4 LYMPHOCYTE COUNT IN HIV-POSITIVE PERSONS EXPOSED TO CRYPTOCOCCUS-NEOFORMANS, Zentralblatt fur Bakteriologie, 283(1), 1995, pp. 127-135
Authors:
JABLONOWSKI H
ARASTEH K
STASZEWSKI S
RUF B
STELLBRINK HJ
SCHRAPPE M
STOEHR A
HAASE W
SCHOMAKER U
ROTHE BV
THOMIS J
STILLE W
LAGE M
POHLE HD
ALBRECHT H
FATKENHEUER G
DIEHL V
PLETTENBERG A
SCHUSTER D
KNECHTEN H
RUHNKE M
ALEXANDER M
SCHWANDER S
DIETRICH M
RUBBERT A
KALDEN JR
EMMINGER C
EICHENLAUB D
SCHEDEL I
DEICHER H
HEHLMANN R
RASOKAT H
DENGLER HJ
HOFFKEN G
BROCKHAUS W
ZIDEK W
WILKE G
FISCHER JT
ULMER A
PETZOLDT D
PEES HW
ZANGERLE R
DUNCKER D
KRIPPNER H
RIEGER T
KERN P
Citation: H. Jablonowski et al., A DOSE COMPARISON STUDY OF DIDANOSINE IN PATIENTS WITH VERY ADVANCED HIV-INFECTION WHO ARE INTOLERANT TO OR CLINICALLY DETERIORATE ON ZIDOVUDINE, AIDS, 9(5), 1995, pp. 463-469
Authors:
MICHEL D
MARRE E
HAMPL W
ROCZKOS J
MULLER S
HERTENSTEIN B
KERN P
HEYMER B
SALZBERGER B
ARASTEH K
MERTENS T
Citation: D. Michel et al., INTESTINAL CYTOMEGALOVIRUS DISEASE IN IMMUNOCOMPROMISED PATIENTS MAY BE RULED OUT BY SEARCH FOR CYTOMEGALOVIRUS DNA IN STOOL SAMPLES, Journal of clinical microbiology, 33(11), 1995, pp. 3064-3067
Authors:
ALBRECHT H
SKORDE J
ARASTEH K
HEISE W
STELLBRINK HJ
GROSSE G
LAGE M
Citation: H. Albrecht et al., DISSEMINATED TOXOPLASMOSIS IN AIDS PATIENTS - REPORT OF 16 CASES, Scandinavian journal of infectious diseases, 27(1), 1995, pp. 71-74
Authors:
BOGNER JR
KAMPS B
BRODT HR
ARASTEH K
HEISE W
SADRI I
GOEBEL FD
SCHEDEL I
RUNGE J
SCHWANDER S
JABLONOWSKI H
SZELENYI H
EMMINGER C
LOCH O
SCHOFER H
HOCHSCHEID I
BAUMGARTEN R
Citation: Jr. Bogner et al., SURVIVAL OF PATIENTS RECEIVING ZIDOVUDINE BEFORE OR AFTER AIDS DIAGNOSIS - RESULTS OF A GERMAN MULTICENTER STUDY, The Clinical investigator, 72(2), 1994, pp. 111-116
Authors:
VOHRINGER HF
ARASTEH K
Citation: Hf. Vohringer et K. Arasteh, PHARMACOKINETIC OPTIMIZATION IN THE TREATMENT OF PNEUMOCYSTIS-CARINIIPNEUMONIA, Clinical pharmacokinetics, 24(5), 1993, pp. 388-412
Authors:
ALBRECHT H
STELLBRINK HJ
ARASTEH K
Citation: H. Albrecht et al., DIDANOSINE-INDUCED DISORDERS OF GLUCOSE-TOLERANCE, Annals of internal medicine, 119(10), 1993, pp. 1050-1050
Risultati:
1-18
|